T cell avidity and tumor recognition: implications and therapeutic strategies

Overview of attention for article published in Journal of Translational Medicine, September 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent: 11 patents

Readers on

mendeley: 32 Mendeley

Summary Patents

So far, Altmetric has seen 11 patents that reference this research output.

Immunogenic WT-1 peptides and methods of use thereof

Grant US-11859015-B2

United States of America

WT1 HLA class II-binding peptides and compositions and methods comprising same

Grant US-11548924-B2

United States of America

Immunogenic WT-1 peptides and methods of use thereof

Grant US-11414457-B2

United States of America

IMMUNOGENIC WT-1 PEPTIDES AND USES THEREOF

Application EP-3834836-A1

European Patent Office

Immunogenic WT-1 peptides and methods of use thereof

Grant US-10815274-B2

United States of America

Immunogenic WT-1 peptides and methods of use thereof

Grant US-10815273-B2

United States of America

TEIPP NEOANTIGENS AND USES THEREOF

Application WO-2019231326-A1

World Intellectual Property Organisation (WIPO)

WT1 HLA class II-binding peptides and compositions and methods comprising same

Grant US-10221224-B2

United States of America

Immunogenic WT-1 peptides and methods of use thereof

Grant US-10100087-B2

United States of America

Immunogenic WT-1 peptides and methods of use thereof

Grant US-9919037-B2

United States of America

IMMUNOGENIC WT-1 PEPTIDES AND USES THEREOF

Application EP-3117836-A1

European Patent Office